Atlas Trials

Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study

Clinical trial NCT02795143 · WITHDRAWN

Trial details

NCT number
NCT02795143
Sponsor
Massachusetts General Hospital
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Toxic Epidermal Necrolysis
Start date
2016-11-01
Primary completion
2020-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.